Olanzapine And Fluoxetine Capsule
Product Images NDC 42291-656

8 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olanzapine And Fluoxetine (NDC 42291-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olanzapine Structural Formula (Olanzapine And Fluoxetine Capsules 1)

Olanzapine Structural Formula (Olanzapine And Fluoxetine Capsules 1)
Chemical structure of olanzapine, the active ingredient in the Olanzapine and Fluoxetine capsule product by AvKARE.*
FDA Label Image

Fluoxetine Hydrochloride Structural Formula (Olanzapine And Fluoxetine Capsules 2)

Fluoxetine Hydrochloride Structural Formula (Olanzapine And Fluoxetine Capsules 2)
Chemical structure of fluoxetine hydrochloride, showing its molecular connections including a trifluoromethyl group attached to a benzene ring and the hydrochloride salt form indicated.*
FDA Label Image

Figure01 (Olanzapine And Fluoxetine Capsules 3)

Figure01 (Olanzapine And Fluoxetine Capsules 3)
A Kaplan-Meier curve illustrating the proportion of patients with relapse over time in days from randomization. The graph compares two treatments: Fluoxetine (dashed line) and Olanzapine and Fluoxetine (solid line), depicting a lower relapse proportion for the combined treatment group across the observed period.*
FDA Label Image

1 (652 30)

1 (652 30)
Label for Olanzapine and Fluoxetine Capsules USP with strength 3 mg / 25 mg, containing 30 capsules. The label shows the AvKARE brand and includes usage instructions, storage information, and warnings. The product is labeled for prescription use only (Rx Only).*
FDA Label Image

1 (653 30)

1 (653 30)
Packaging label for Olanzapine and Fluoxetine Capsules USP, containing 6 mg olanzapine and 25 mg fluoxetine per capsule. The label shows the AvKARE brand, package size of 30 capsules, and indicates prescription use only (Rx Only). Additional label text includes storage instructions and warnings about medication guides and safe use.*
FDA Label Image

1 (654 30)

1 (654 30)
Packaging label for Olanzapine and Fluoxetine Capsules USP, strength 6 mg / 50 mg. The label shows the AvKARE brand, NDC 42291-654-30, and indicates a package count of 30 capsules. It includes regulatory text, storage instructions, a barcode, and a QR code.*
FDA Label Image

1 (655 30)

1 (655 30)
Olanzapine and Fluoxetine Capsules USP 12 mg / 25 mg in a package labeled AvKARE. The container holds 30 capsules for oral use. The label includes storage instructions, barcode, QR code, and manufacturer information from AvKARE.*
FDA Label Image

1 (656 30)

1 (656 30)
Olanzapine and Fluoxetine Capsules USP, 12 mg / 50 mg, packaged in a container of 30 capsules. The label shows the AvKARE brand name and includes usage instructions, storage information, and regulatory details, including the National Drug Code (NDC) 42291-656-30, indicating it is for prescription use only (Rx Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.